High blood pressure registry
Registry of Arterial Hypertension: "Study of Modern Phenotypes of Arterial Hypertension, Including Secondary Forms, in Order to Create Personalized Methods of Treatment"
This project gathers medical data from adults with high blood pressure to see how primary care clinics follow current treatment recommendations.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10400 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation Government |
| Locations | 17 sites (Moscow, Moscow Oblast and 16 other locations) |
| Trial ID | NCT04160533 on ClinicalTrials.gov |
What this trial studies
This registry uses a secure, web-accessible software platform to collect de-identified outpatient data from adults (18+) with a diagnosis of arterial hypertension at participating primary care clinics. Participating physicians are trained and enter information from patient records into the registry through a certified secure channel, with user rights and a user guide in place to minimize entry errors. The registry enables automated comparison of recorded diagnostic and treatment actions against current clinical recommendations. Aggregated analyses aim to identify care gaps and inform approaches to improve the timeliness, accessibility, and quality of primary care for hypertension.
Who should consider this trial
Good fit: Adults aged 18 and older with an established diagnosis of arterial hypertension who receive care at participating clinics and consent to inclusion of their de-identified data are eligible.
Not a fit: People without a diagnosis of arterial hypertension or those treated outside the participating clinics will not be included and are unlikely to benefit directly from this registry.
Why it matters
Potential benefit: If successful, the registry could reveal gaps in routine care and support targeted improvements that improve blood pressure control and reduce cardiovascular complications.
How similar studies have performed: Similar hypertension registries have been widely used and have helped identify care gaps and support quality-improvement efforts, so this approach is established rather than entirely novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: The diagnosis of arterial hypertension - Exclusion Criteria: No diagnosis of arterial hypertension \-
Where this trial is running
Moscow, Moscow Oblast and 16 other locations
- Federal State Budgetary Institution "National Medical Research Center of Cardiology named after academician E.I. Chazov" of the Ministry of Healthcare of the Russian Federation — Moscow, Moscow Oblast, Russia (Recruiting)
- State Healthcare Institution "Engels City Polyclinic No. 2 — Engel's, Russia (Recruiting)
- State Healthcare Institution "Engels City Polyclinic No. 4 — Engel's, Russia (Recruiting)
- State budgetary health institution of the Kemerovo region "Kemerovo Regional Clinical Cardiology Dispensary named after Academician L.S. Barbarash — Kemerovo, Russia (Recruiting)
- State budgetary institution of the ryazan region "regional clinical cardiological dispensary" — Ryazan, Russia (Recruiting)
- Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №1 — Taganrog, Russia (Recruiting)
- Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №2 — Taganrog, Russia (Recruiting)
- Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №3 — Taganrog, Russia (Recruiting)
- Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №4 — Taganrog, Russia (Recruiting)
- Municipal budgetary institution of public health "City polyclinic №2" Taganrog Branch №1 — Taganrog, Russia (Recruiting)
- Municipal budgetary institution of public health "City polyclinic №2" Taganrog Branch №4 — Taganrog, Russia (Recruiting)
- Municipal budgetary institution of public health services "City ambulance hospital" city of Taganrog — Taganrog, Russia (Recruiting)
- State Autonomous Healthcare Institution of the Tyumen Region "Tyumen Institute of Therapy — Tyumen, Russia (Recruiting)
- Municipal Health Institution "City Hospital No. 1" Volgodonsk — Volgodonsk, Russia (Recruiting)
- Municipal health institution "City polyclinic №1" Volgodonsk — Volgodonsk, Russia (Recruiting)
- Municipal health institution "City polyclinic №3" Volgodonsk — Volgodonsk, Russia (Recruiting)
- State budgetary institution of public health "Volgograd regional clinical hospital No. 1" clinic — Volgograd, Russia (Recruiting)
Study contacts
- Study coordinator: Anna Aksenova, MD
- Email: aksenovaannav@gmail.com
- Phone: +74954146186
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.